Meta-analysis of trials comparing minimally-invasive and open liver resections for hepatocellular carcinoma
- PMID: 21920552
- DOI: 10.1016/j.jss.2011.07.008
Meta-analysis of trials comparing minimally-invasive and open liver resections for hepatocellular carcinoma
Abstract
Background: Recent literature suggests that minimally-invasive hepatectomy (MIH) for hepatocellular carcinoma (HCC) is associated with better perioperative results and similar oncologic outcomes compared to open hepatectomy (OH). However, previous reports have been limited by small sample size and single-institution design.
Methods: To overcome these limitations, we performed a meta-analysis of studies comparing MIH and OH in patients with HCC using a random-effects model.
Results: Nine eligible studies were identified that included 227 patients undergoing MIH and 363 undergoing OH. Patients were similar respect to age, gender, rates of cirrhosis, hepatitis C infection, tumour size, and American Society of Anesthesiology classification. The MIH group had lower rates of hepatitis B infection. There were no differences in type of resection (anatomic or non-anatomic), use of Pringle's maneuver, and operative time. Patients undergoing MIH had less blood loss [difference -217 mL; 95% confidence interval (CI), -314 to -121], lower rates of transfusion [odds ratio (OR), 0.38; 95% CI, 0.24 to 0.59], shorter postoperative stay (difference -5 days; 95% CI, -7.84 to -2.25), lower rates of positive margins (OR, 0.30; 95% CI, 0.12 to 0.69) and perioperative complications (OR, 0.45; 95% CI, 0.31 to 0.66). Survival outcomes were similar in the two groups.
Conclusions: Although patient selection might have influenced some of the observed outcomes, MIH was associated with decreased blood loss, transfusions, rates of positive resection margins, overall and specific morbidity, and hospital stay. Survival outcomes did not differ between MIH and OH, although further studies are needed to evaluate the impact of MIH on long-term results.
Copyright © 2011 Elsevier Inc. All rights reserved.
Similar articles
-
Long-Term Oncological Safety of Minimally Invasive Hepatectomy in Patients with Hepatocellular Carcinoma: A Case-Control Study.Ann Acad Med Singap. 2016 Mar;45(3):91-7. Ann Acad Med Singap. 2016. PMID: 27146461
-
Minimal-invasive versus open hepatectomy for hepatocellular carcinoma: Comparison of postoperative outcomes and long-term survivals using propensity score matching analysis.Surg Oncol. 2018 Dec;27(4):751-758. doi: 10.1016/j.suronc.2018.10.005. Epub 2018 Oct 9. Surg Oncol. 2018. PMID: 30449503
-
Comparing Outcomes of Minimally Invasive and Open Hepatectomy for Primary Liver Malignancies in Patients with Low-MELD Cirrhosis.J Gastrointest Surg. 2023 Nov;27(11):2424-2433. doi: 10.1007/s11605-023-05817-3. Epub 2023 Aug 24. J Gastrointest Surg. 2023. PMID: 37620660
-
Laparoscopic Liver Surgery: What Are the Advantages in Patients with Cirrhosis and Portal Hypertension? Systematic Review and Meta-Analysis with Personal Experience.J Laparoendosc Adv Surg Tech A. 2020 Oct;30(10):1054-1065. doi: 10.1089/lap.2020.0408. Epub 2020 Jul 20. J Laparoendosc Adv Surg Tech A. 2020. PMID: 32707003
-
Comparison of survival and post-operation outcomes for minimally invasive versus open hepatectomy in hepatocellular carcinoma: A systematic review and meta-analysis of case-matched studies.Front Oncol. 2022 Oct 20;12:1021804. doi: 10.3389/fonc.2022.1021804. eCollection 2022. Front Oncol. 2022. PMID: 36338679 Free PMC article.
Cited by
-
Outcomes and Patient Selection in Laparoscopic vs. Open Liver Resection for HCC and Colorectal Cancer Liver Metastasis.Cancers (Basel). 2023 Feb 12;15(4):1179. doi: 10.3390/cancers15041179. Cancers (Basel). 2023. PMID: 36831521 Free PMC article. Review.
-
Long-term outcome of laparoscopic versus open liver resection for hepatocellular carcinoma: a case-controlled study with propensity score matching.Surg Endosc. 2014 Mar;28(3):950-60. doi: 10.1007/s00464-013-3254-3. Epub 2013 Oct 23. Surg Endosc. 2014. PMID: 24149856
-
Laparoscopic surgery of liver tumors.Langenbecks Arch Surg. 2013 Oct;398(7):931-8. doi: 10.1007/s00423-013-1117-y. Epub 2013 Sep 18. Langenbecks Arch Surg. 2013. PMID: 24046095 Review.
-
Percutaneous Microwave Ablation Under CT Guidance for Hepatocellular Carcinoma: a Single Institutional Experience.J Gastrointest Cancer. 2018 Sep;49(3):295-301. doi: 10.1007/s12029-017-9951-8. J Gastrointest Cancer. 2018. PMID: 28530021
-
Surgical treatment of hepatocellular carcinoma in the era of COVID-19 pandemic: A comprehensive review of current recommendations.World J Clin Cases. 2021 May 26;9(15):3517-3530. doi: 10.12998/wjcc.v9.i15.3517. World J Clin Cases. 2021. PMID: 34046452 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical